The effects of elafibranor in people with primary biliary cholangitis: a plain language summary

Simple item page
dc.article.number2444861
dc.catalogadorpva
dc.contributor.authorKowdley, Kris V.
dc.contributor.authorBowlus, Christopher
dc.contributor.authorLevy, Cynthia
dc.contributor.authorAkarca, Ulus S.
dc.contributor.authorAlvares-da-Silva, Mario Reis
dc.contributor.authorAndreone, Pietro
dc.contributor.authorArrese, Marco
dc.contributor.authorFrancque, Sven M.
dc.contributor.authorHeneghan, Michael A.
dc.contributor.authorInvernizzi, Pietro
dc.contributor.authorJones, David
dc.contributor.authorLawitz, Eric
dc.contributor.authorMayo, Marlyn J.
dc.contributor.authorSwain, Mark G.
dc.contributor.authorVargas, Victor
dc.contributor.authorVierling, John M.
dc.contributor.authorVillamil, Alejandra
dc.contributor.authorAddy, Carol
dc.contributor.authorDietrich, Julie
dc.contributor.authorMazain, Sarah
dc.contributor.authorTaddé, Bachirou
dc.contributor.authorMiller, Benjamin
dc.contributor.authorShu, Jianfen
dc.contributor.authorZein, Claudia O.
dc.contributor.authorRoberts, Carol
dc.contributor.authorWright, Gail
dc.contributor.authorSchattenberg, Jörn M.
dc.date.accessioned2025-03-06T16:08:21Z
dc.date.available2025-03-06T16:08:21Z
dc.date.issued2025
dc.description.abstractThis is a plain language summary describing the phase 3 clinical trialcalled ‘ELATIVE®’. Primary biliary cholangitis (PBC) is a rare disease of the liverthat can get worse over time and can be potentially life threatening. Livingwith PBC can also reduce a person’s quality of life. There are currently notmany treatment options available for PBC. The ELATIVE® clinical trial testedhow well a potential new treatment called ‘elafibranor’ works in treatingpeople with PBC.
dc.fechaingreso.objetodigital2025-03-06
dc.format.extent12 páginas
dc.fuente.origenSCOPUS
dc.identifier.doi10.1080/23995270.2024.2444861
dc.identifier.issn2399-5270
dc.identifier.scopusidSCOPUS_ID:85216883308
dc.identifier.urihttps://doi.org/10.1080/23995270.2024.2444861
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/102398
dc.information.autorucEscuela de Medicina; Arrese, Marco; 0000-0002-0499-4191; 76095
dc.issue.numero1
dc.language.isoen
dc.nota.accesocontenido completo
dc.publisherTaylor and Francis Ltd.
dc.revistaFuture Rare Diseases
dc.rightsacceso abierto
dc.rights.licenseCC BY-NC 4.0
dc.rights.urihttps://creativecommons.org/licenses/by-nc/4.0/
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.subject.ods03 Good health and well-being
dc.subject.odspa03 Salud y bienestar
dc.titleThe effects of elafibranor in people with primary biliary cholangitis: a plain language summary
dc.typeartículo
dc.volumen5
sipa.codpersvinculados76095
sipa.trazabilidadSCOPUS;2025-02-23
sipa.trazabilidadORCID;2025-03-03
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
The effects of elafibranor in people with primary biliary cholangitis a plain language summary.pdf
Size:
2.89 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas